JMIR Mental Health (Apr 2022)

A Serious Game for Young People With First Episode Psychosis (OnTrack>The Game): Qualitative Findings of a Randomized Controlled Trial

  • Samantha Jankowski,
  • Kathleen Ferreira,
  • Franco Mascayano,
  • Effy Donovan,
  • Reanne Rahim,
  • Michael L Birnbaum,
  • Sabrina Yum-Chan,
  • Deborah Medoff,
  • Bethany Marcogliese,
  • Lijuan Fang,
  • Terriann Nicholson,
  • Lisa Dixon

DOI
https://doi.org/10.2196/33526
Journal volume & issue
Vol. 9, no. 4
p. e33526

Abstract

Read online

BackgroundSeveral studies have shown the benefits of coordinated specialty care (CSC) for individuals with first episode psychosis; however, pathways to care are marred by lack of knowledge, stigma, and difficulties with treatment engagement. Serious games or video interventions may provide a way to address these factors. ObjectiveThis study focuses on qualitative results of a randomized controlled trial comparing OnTrack>The Game (OTG) with recovery videos (RVs) on engagement, stigma, empowerment, hope, recovery, and understanding of psychosis in clients receiving CSC. Clinicians are also interviewed regarding their perceptions of the interventions and suggestions for improvement. MethodsA total of 16 clients aged 16-30 years, with first episode psychosis attending a CSC program in New York State, and 9 clinicians participated in the qualitative interviews. Interviews were analyzed using the rapid identification of themes from audio recordings method. ResultsFor clients, themes included relatability of game content, an increased sense of hope and the possibility of recovery, decreased self-stigma and public stigma, increased understanding of the importance of social support, and increased empowerment in the OTG group. Clinicians had a preference for RV and provided suggestions for dissemination and implementation. ConclusionsThemes that may help inform future research in this area, particularly regarding dissemination and implementation of OTG and RV, emerged. Trial RegistrationClinicalTrials.gov NCT03390491; https://clinicaltrials.gov/ct2/show/NCT03390491